Kyverna Therapeutics, Inc. (KYTX) vs Zura Bio Limited (ZURA)
A side-by-side comparison of Kyverna Therapeutics, Inc. and Zura Bio Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYTX
Kyverna Therapeutics, Inc.
$6.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZURA
Zura Bio Limited
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KYTX vs ZURA
growth of $100 · dividends reinvested · last 3yKYTX -78.9% (-40.5%/yr)ZURA +0.3% (+0.1%/yr)ZURA compounded faster over this window
KYTX ZURA
KYTX vs ZURA: by the numbers
- •ZURA is the larger company ($376M vs $374M market cap).
Metrics side by side
Valuation
| Metric | KYTX | ZURA |
|---|---|---|
| P/B ratio | 2.26 | 1.91 |
Profitability
| Metric | KYTX | ZURA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -92.20% | -43.51% |
| ROIC | -80.67% | -47.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.